Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9303)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2015 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. World J Gastroenterol 2015; 21(1): 196-213 [PMID: 25574092 DOI: 10.3748/wjg.v21.i1.196] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i1/196.htm |
| Number | Citing Articles |
| 1 |
Xiaozheng Cao, Kaiqun Ren, Zhengwei Song, Duo Li, Meifang Quan, Yu Zheng, Jianguo Cao, Wenbin Zeng, Hui Zou. 7-Difluoromethoxyl-5,4′-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells. Oncology Reports 2016; 36(2): 1157 doi: 10.3892/or.2016.4848
|
| 2 |
Bao‑Ying Fei, Xujun He, Jie Ma, Mei Zhang, Rui Chai. FoxM1 is associated with metastasis in colorectal cancer through induction of the epithelial‑mesenchymal transition. Oncology Letters 2017; doi: 10.3892/ol.2017.7022
|
| 3 |
Wen-Tao Wang, Shuo Zhu, Ying Ding, Li Yang, Cai-Zhong Chen, Qing-Hai Ye, Yuan Ji, Meng-Su Zeng, Sheng-Xiang Rao. T 1 mapping on gadoxetic acid-enhanced MR imaging predicts recurrence of hepatocellular carcinoma after hepatectomy. European Journal of Radiology 2018; 103: 25 doi: 10.1016/j.ejrad.2018.03.027
|
| 4 |
Ming Han, Hongping Lu, Kai Han, Xiaoxue Yuan, Shunai Liu, Yun Wang, Jing Zhao, Pu Liang, Jun Cheng. XTP8 promotes hepatocellular carcinoma growth by forming a positive feedback loop with FOXM1 oncogene. Biochemical and Biophysical Research Communications 2019; 515(3): 455 doi: 10.1016/j.bbrc.2019.05.164
|
| 5 |
Deeptashree Nandi, Pradeep Singh Cheema, Aakriti Singal, Hina Bharti, Alo Nag. Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.751271
|
| 6 |
Weizheng Liang, Yan Zhao, Qingxue Meng, Wenjie Jiang, Shoulong Deng, Jun Xue. The role of long non-coding RNA in hepatocellular carcinoma. Aging 2024; 16(4): 4052 doi: 10.18632/aging.205523
|
| 7 |
Takuro Kyuno, Takayuki Kohno, Takumi Konno, Hiroshi Yamaguchi, Daisuke Kyuno, Masafumi Imamura, Yasutoshi Kimura, Takashi Kojima, Ichiro Takemasa. Glucose-Dependent FOXM1 Promotes Epithelial-to-Mesenchymal Transition Via Cellular Metabolism and Targeting Snail in Human Pancreatic Cancer. Pancreas 2020; 49(2): 273 doi: 10.1097/MPA.0000000000001485
|
| 8 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3375 doi: 10.1007/978-3-319-26956-6_183
|
| 9 |
Hua-Yu Wu, Li-Feng Luo, Fang Wei, Hong-Mian Jiang. Comprehensive clinicopathological significance and putative transcriptional mechanisms of Forkhead box M1 factor in hepatocellular carcinoma. World Journal of Surgical Oncology 2023; 21(1) doi: 10.1186/s12957-023-03250-z
|
| 10 |
Jinfeng Zhu, Jiefeng Zhao, Chen Luo, Zhengming Zhu, Xingyu Peng, Xiaojian Zhu, Kang Lin, Fanqin Bu, Wenjun Zhang, Qing Li, Kai Wang, Zhigang Hu, Xin Yu, Leifeng Chen, Rongfa Yuan. FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression. Cell Death & Disease 2022; 13(5) doi: 10.1038/s41419-022-04960-0
|
| 11 |
Linxin Teng, Kaiyuan Wang, Yu Liu, Yanxia Ma, Weiping Chen, Lei Bi. Based on Integrated Bioinformatics Analysis Identification of Biomarkers in Hepatocellular Carcinoma Patients from Different Regions. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/1742341
|
| 12 |
Nishit K. Mukhopadhyay, Vaibhav Chand, Akshay Pandey, Dragana Kopanja, Janai R. Carr, Yi-Ju Chen, Xiubei Liao, Pradip Raychaudhuri. Plk1 Regulates the Repressor Function of FoxM1b by inhibiting its Interaction with the Retinoblastoma Protein. Scientific Reports 2017; 7(1) doi: 10.1038/srep46017
|
| 13 |
Xiao Fu, Yixuan Yang, Dazhi Zhang. Molecular mechanism of albumin in suppressing invasion and metastasis of hepatocellular carcinoma. Liver International 2022; 42(3): 696 doi: 10.1111/liv.15115
|
| 14 |
Xiaorong Zhang, Yifan Zhong, Qing Yang. FOXM1 Upregulates O-GlcNAcylation Level Via The Hexosamine Biosynthesis Pathway to Promote Angiogenesis in Hepatocellular Carcinoma. Cell Biochemistry and Biophysics 2024; 82(3): 2767 doi: 10.1007/s12013-024-01393-8
|
| 15 |
Xiaocheng Cao, Lihua Liu, Qing Yuan, Xiang Li, Yinghong Cui, Kaiqun Ren, Chang Zou, A. Chen, Chang Xu, Yebei Qiu, Meifang Quan, Jiansong Zhang, Jianguo Cao, Xiangding Chen. RETRACTED ARTICLE: Isovitexin reduces carcinogenicity and stemness in hepatic carcinoma stem-like cells by modulating MnSOD and FoxM1. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1244-6
|
| 16 |
Chuan Tian, Haixia Wu, Chan Li, Xia Tian, Yong Sun, Enqiang Liu, Xiuyong Liao, Wei Song. Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinoma. Gene Therapy 2018; 25(4): 312 doi: 10.1038/s41434-018-0029-4
|
| 17 |
Hengzheng He, Jian Zhou, Fahui Cheng, Huijuan Li, Yangya Quan. MiR-3677-3p promotes development and sorafenib resistance of hepatitis B-related hepatocellular carcinoma by inhibiting FOXM1 ubiquitination. Human Cell 2023; 36(5): 1773 doi: 10.1007/s13577-023-00945-z
|
| 18 |
Runze Shang, Meng Pu, Yu Li, Desheng Wang. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression. Oncology Reports 2017; 37(4): 2261 doi: 10.3892/or.2017.5472
|
| 19 |
Tingting Zhang, Guangtao Ma, Yan Zhang, Hongda Huo, Yuqian Zhao. miR-216b inhibits glioma cell migration and invasion through suppression of FoxM1. Oncology Reports 2017; 38(3): 1751 doi: 10.3892/or.2017.5824
|
| 20 |
Ogechi Ogoke, Osama Yousef, Cortney Ott, Allison Kalinousky, Wayne Lin, Claire Shamul, Shatoni Ross, Natesh Parashurama. Modeling Liver Organogenesis by Recreating Three-Dimensional Collective Cell Migration: A Role for TGFβ Pathway. Frontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.621286
|
| 21 |
Peng Wang, Jianmin Sun, Chengming Sun, Haoran Zhao, YuBao Zhang, Jing Chen. BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1. Cancer Biology & Therapy 2023; 24(1) doi: 10.1080/15384047.2023.2225884
|
| 22 |
Kuiliang Liu, Jianghao Fan, Jing Wu. Forkhead Box Protein J1 (FOXJ1) is Overexpressed in Colorectal Cancer and Promotes Nuclear Translocation of β-Catenin in SW620 Cells. Medical Science Monitor 2017; 23: 856 doi: 10.12659/MSM.902906
|
| 23 |
Catia Giovannini, Francesca Fornari, Valentina Indio, Davide Trerè, Matteo Renzulli, Francesco Vasuri, Matteo Cescon, Matteo Ravaioli, Alessia Perrucci, Annalisa Astolfi, Fabio Piscaglia, Laura Gramantieri. Direct Antiviral Treatments for Hepatitis C Virus Have Off-Target Effects of Oncologic Relevance in Hepatocellular Carcinoma. Cancers 2020; 12(9): 2674 doi: 10.3390/cancers12092674
|
| 24 |
Jun Dai, Lili Yang, Jinyu Wang, Ying Xiao, Qiurong Ruan. Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System Review. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/352478
|
| 25 |
Liang Wang, Caiyan Shi, Jie Yu, Yilin Xu. FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-021-02372-2
|
| 26 |
Shi-Xiong Liu, Yun Zhou, Li Zhao, Ling-Shan Zhou, Jie Sun, Ge-Jing Liu, Ying-Shi Du, Yong-Ning Zhou. Thiostrepton confers protection against reactive oxygen species-related apoptosis by restraining FOXM1-triggerred development of gastric cancer. Free Radical Biology and Medicine 2022; 193: 385 doi: 10.1016/j.freeradbiomed.2022.09.018
|
| 27 |
Soheila Borhani, Andrei L. Gartel. FOXM1: a potential therapeutic target in human solid cancers. Expert Opinion on Therapeutic Targets 2020; 24(3): 205 doi: 10.1080/14728222.2020.1727888
|
| 28 |
Yuan Li, Liqing Lu, Jian Tu, Jing Zhang, Ting Xiong, Wei Fan, Jiaohong Wang, Meng Li, Yibu Chen, Justin Steggerda, Hui Peng, Yongheng Chen, Tony W.H. Li, Zhi‐Gang Zhou, José M. Mato, Ekihiro Seki, Ting Liu, Heping Yang, Shelly C. Lu. Reciprocal Regulation Between Forkhead Box M1/NF‐κB and Methionine Adenosyltransferase 1A Drives Liver Cancer. Hepatology 2020; 72(5): 1682 doi: 10.1002/hep.31196
|
| 29 |
Jing Yan, Bei Xie, Shuli Zou, Li Huang, Ye Tian, Jing Li, Zhiheng Peng, Zhuan Liu, Bin Ma, Linjing Li. Value of Biomarkers in Epithelial–Mesenchymal Transition Models Of Liver Cancer Under Different Interventions: A Meta-Analysis. Future Oncology 2022; 18(36): 4031 doi: 10.2217/fon-2022-0344
|
| 30 |
Akash Shukla, Abhinav Jain. Hepatocellular Carcinoma with Hepatic Vein and Inferior Vena Cava Invasion. Journal of Clinical and Experimental Hepatology 2023; 13(5): 813 doi: 10.1016/j.jceh.2023.03.006
|
| 31 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_183-1
|
| 32 |
Chun-Peng Yu, Shui Yu, Lei Shi, Song Wang, Zi-Xiang Li, Yan-Hua Wang, Cheng-Jian Sun, Jun Liang. FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1. Molecular Medicine Reports 2017; 16(4): 5181 doi: 10.3892/mmr.2017.7223
|
| 33 |
Zhongqin Gong, Jianqing Yu, Shucai Yang, Paul B.S. Lai, George G. Chen. FOX transcription factor family in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(1): 188376 doi: 10.1016/j.bbcan.2020.188376
|
| 34 |
Hironobu Yamashita, Vasty Osei Amponsa, Joshua I. Warrick, Zongyu Zheng, Peter E. Clark, Jay D. Raman, Xue-Ru Wu, Cathy Mendelsohn, David J. DeGraff. On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer. Nature Reviews Urology 2017; 14(2): 98 doi: 10.1038/nrurol.2016.239
|
| 35 |
Kyle J. Thompson, Rebecca Garland Austin, Shayan S. Nazari, Keith S. Gersin, David A. Iannitti, Iain H. McKillop. Altered fatty acid‐binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma. Liver International 2018; 38(6): 1074 doi: 10.1111/liv.13639
|
| 36 |
Yasin Tosun, Mehmet Velidedeoğlu, Ozan Akıncı, Sina Ferahman, Nuray Kepil, Osman Baran Tortum. Comparison of the effectiveness of i-scan and conventional endoscopy in the detection of the endoscopic signs of atrophic gastritis: A clinical trial. Arab Journal of Gastroenterology 2022; 23(2): 70 doi: 10.1016/j.ajg.2021.12.001
|
| 37 |
Gang Zhang, Guangye Zhang. Upregulation of FoxP4 in HCC promotes migration and invasion through regulation of EMT. Oncology Letters 2019; doi: 10.3892/ol.2019.10049
|
| 38 |
Zhaohua Xiao, Yang Jia, Wenpeng Jiang, Zhou Wang, Zhiping Zhang, Yanyun Gao. FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma. Thoracic Cancer 2018; 9(8): 997 doi: 10.1111/1759-7714.12776
|
| 39 |
Saeideh Maleki, James Jabalee, Cathie Garnis. The Role of Extracellular Vesicles in Mediating Resistance to Anticancer Therapies. International Journal of Molecular Sciences 2021; 22(8): 4166 doi: 10.3390/ijms22084166
|
| 40 |
Kumari Swati, Sudhir Rama Varma, R. P. Parameswari, Siva Prasad Panda, Mohit Agrawal, Anand Prakash, Dhruv Kumar, Prasoon Agarwal. Computational exploration of FOXM1 inhibitors for glioblastoma: an integrated virtual screening and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics 2024; : 1 doi: 10.1080/07391102.2024.2308772
|
| 41 |
Yebei Qiu, Xiaocheng Cao, Lihua Liu, Xiaozheng Cao, Qing Yuan, Xiang Li, Yinghong Cui, Chang Xu, Chang Zou, Kaiqun Ren, Jianguo Cao. <p>Modulation of MnSOD and FoxM1 Is Involved in Invasion and EMT Suppression by Isovitexin in Hepatocellular Carcinoma Cells</p>. Cancer Management and Research 2020; : 5759 doi: 10.2147/CMAR.S245283
|
| 42 |
Huiling Yang, Li Wen, Mingling Wen, Tao Liu, Lisheng Zhao, Bo Wu, Yuyu Yun, Wenchao Liu, Hao Wang, Yu Wang, Ning Wen. FoxM1 promotes epithelial–mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop. Anti-Cancer Drugs 2018; 29(3): 216 doi: 10.1097/CAD.0000000000000585
|
| 43 |
Camille Emprou, Pauline Le Van Quyen, Jérémie Jégu, Nathalie Prim, Noëlle Weingertner, Eric Guérin, Erwan Pencreach, Michèle Legrain, Anne‐Claire Voegeli, Charlotte Leduc, Bertrand Mennecier, Pierre‐Emmanuel Falcoz, Anne Olland, Nicolas Santelmo, Elisabeth Quoix, Gilbert Massard, Dominique Guenot, Marie‐Pierre Chenard, Michèle Beau‐Faller. SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients. Cancer Medicine 2018; 7(7): 3278 doi: 10.1002/cam4.1545
|
| 44 |
YanChen LI, RuiXuan GENG, Ke ZHAO, YeYe CHEN, QingFei ZHENG, ZhiBo ZHENG. Research progress of transcription factor FoxM1 in malignant tumors. SCIENTIA SINICA Vitae 2023; 53(9): 1239 doi: 10.1360/SSV-2022-0131
|
| 45 |
Kuo-Shyang Jeng, Ssu-Jung Lu, Chih-Hsuan Wang, Chiung-Fang Chang. Liver Fibrosis and Inflammation under the Control of ERK2. International Journal of Molecular Sciences 2020; 21(11): 3796 doi: 10.3390/ijms21113796
|
| 46 |
Jing Zhang, Xiao-Yu Chen, Ke-Jian Huang, Wei-Dong Wu, Tao Jiang, Jun Cao, Li-Sheng Zhou, Zheng-Jun Qiu, Chen Huang. Expression of FoxM1 and the EMT-associated protein E-cadherin in gastric cancer and its clinical significance. Oncology Letters 2016; 12(4): 2445 doi: 10.3892/ol.2016.4917
|
| 47 |
Funda Demirtas Korkmaz, Irem Dogan Turacli, Guldal Esendagli, Abdullah Ekmekci. Effects of thiostrepton alone or in combination with selumetinib on triple-negative breast cancer metastasis. Molecular Biology Reports 2022; 49(11): 10387 doi: 10.1007/s11033-022-07751-0
|
| 48 |
Zi-Ying Zhou, Xiao-Yang Han, Lian-Qi Sun, Si-Yan Li, Si-Tu Xue, Zhuo-Rong Li. Structure-based virtual screening identified novel FOXM1 inhibitors as the lead compounds for ovarian cancer. Frontiers in Chemistry 2022; 10 doi: 10.3389/fchem.2022.1058256
|
| 49 |
Bin Zhang, Yajing Zhang, Xiaoping Zou, Anthony WH Chan, Rui Zhang, Terence Kin-Wah Lee, Hang Liu, Eunice Yuen-Ting Lau, Nicole Pui-Yu Ho, Paul BS Lai, Yue-Sun Cheung, Ka-Fai To, Hoi Kin Wong, Kwong Wai Choy, Vincent W Keng, Larry MC Chow, Kenrick KY Chan, Alfred S Cheng, Ben CB Ko. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma. The Journal of Pathology 2017; 243(4): 418 doi: 10.1002/path.4976
|
| 50 |
Teng Ma, Ye Zhao, Qitong Lu, Yun Lu, Zhiyong Liu, Tao Xue, Yongfeng Shao. MicroRNA-30c functions as a tumor suppressor via targeting SNAI1 in esophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy 2018; 98: 680 doi: 10.1016/j.biopha.2017.12.095
|
| 51 |
Zhi‐Qiang Qiu, Xiang Wang, Xiang‐Wen Ji, Fen‐Jun Jiang, Xin‐Ye Han, Wei‐Li Zhang, Yi‐Hua An. The clinical relevance of epithelial‐mesenchymal transition and its correlations with tumorigenic immune infiltrates in hepatocellular carcinoma. Immunology 2022; 166(2): 185 doi: 10.1111/imm.13465
|
| 52 |
Jingcheng Wang, Yang Tian, Hui Chen, Hui Li, Shusen Zheng. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8871
|